angiotensinconvert
enzym
highli
express
kidney
proxim
tubul
cleav
angiotensin
ang
ii
ang
urinari
level
increas
diabet
suggest
may
shed
tubular
cell
aim
studi
determin
shed
proxim
tubular
cell
character
fragment
studi
pathway
shed
studi
involv
primari
cultur
mous
proxim
tubular
cell
activ
measur
use
synthet
substrat
analysi
fragment
immunoblot
mass
spectrometri
cultur
media
mous
proxim
tubular
cell
demonstr
timedepend
increas
activ
suggest
constitut
shed
detect
media
two
band
kda
kda
immunoblot
contrast
fulllength
appear
kda
cell
lysat
mous
kidney
cortex
mass
spectrometri
two
deglycosyl
fragment
identifi
peptid
match
mous
posit
respect
cterminu
peptid
fragment
contain
nontrypt
site
suggest
met
candid
cleavag
site
incub
cell
high
dglucos
mm
lesser
extent
ang
ii
h
increas
activ
media
effect
block
inhibit
disintegrin
metalloproteinas
adam
high
dglucos
increas
activ
cell
lysat
data
indic
two
glycosyl
fragment
constitut
shed
mous
proxim
tubular
cell
shed
stimul
high
dglucos
least
partli
via
pathway
result
suggest
proxim
tubular
shed
may
increas
diabet
could
enhanc
degrad
ang
ii
tubular
lumen
increas
level
ang
angiotensinconvert
enzym
compon
reninangiotensin
system
contain
singl
hemgh
zincdepend
catalyt
site
degrad
vasoconstrictor
angiotensin
ang
ii
vasodil
ang
although
found
mani
tissu
highli
express
kidney
particularli
within
cell
proxim
tubul
pt
experiment
studi
suggest
protect
renal
diseas
progress
thu
gene
knockout
ko
mice
develop
acceler
ang
iimedi
glomerulosclerosi
suscept
kidney
injuri
type
diabet
akita
model
moreov
akita
diabet
mice
administr
exogen
human
recombin
attenu
blood
pressur
glomerular
injuri
recent
report
podocytespecif
overexpress
human
attenu
streptozotocin
stz
induc
diabet
nephropathi
mice
kidney
biopsi
patient
type
diabet
kidney
diseas
glomerular
tubular
express
decreas
may
result
increas
ang
ii
level
subsequ
enhanc
renal
injuri
contrast
mice
diabet
nephropathi
exhibit
diminish
glomerular
express
increas
tubular
suggest
compensatori
mechan
counteract
effect
increas
ang
ii
type
integr
membran
protein
share
homolog
angiotensinconvert
enzym
ace
ntermin
extracellular
catalyt
domain
unlik
ace
howev
block
ace
inhibitor
may
act
upon
metalloproteas
result
cleavag
extracellular
shed
cterminu
cell
surfac
inde
ectodomain
shed
solubl
form
report
occur
human
embryon
kidney
hek
cell
airway
epitheli
cell
mediat
enzym
tumor
necrosi
factor
tnf
convertas
tace
also
known
member
disintegrin
metalloproteinas
famili
solubl
first
report
human
urin
immunoblot
urinari
level
increas
dbdb
diabet
mice
mice
stzdiabet
effect
appear
due
passag
enzym
across
glomerular
filtrat
barrier
furthermor
urinari
level
increas
chronic
kidney
diseas
ckd
patient
diabet
close
associ
type
diabet
mellitu
human
studi
urinari
fragment
detect
smaller
molecular
mass
compar
fulllength
recent
chodavarapu
et
al
demonstr
increas
renal
express
diabet
dbdb
mice
associ
increas
urinari
excret
treatment
insulin
sensit
rosiglitazon
decreas
renal
express
urinari
level
accordingli
data
suggest
may
shed
tubular
cell
urinari
space
process
may
enhanc
diabet
via
activ
regard
pt
cell
repres
potenti
sourc
urinari
howev
effect
high
extracellular
glucos
ang
ii
pt
shed
role
cell
explor
furthermor
fragment
shed
pt
cell
character
regard
possibl
cleavag
site
within
aim
studi
therefor
first
determin
shed
primari
cultur
mous
pt
cell
character
shed
fragment
immunoblot
analysi
mass
spectrometri
importantli
effect
high
dglucos
ang
ii
ectodomain
shed
examin
role
result
reveal
two
glycosyl
fragment
kda
constitut
shed
mous
pt
cell
high
glucos
lesser
extent
ang
ii
stimul
shed
via
pathway
studi
involv
primari
cultur
mous
proxim
tubular
cell
describ
mice
hous
accord
canadian
council
anim
care
ccac
guidelin
experiment
protocol
approv
anim
care
committe
univers
ottawa
male
mice
obtain
charl
river
laboratori
saintconst
quebec
canada
gene
ko
mice
background
obtain
duke
univers
medic
center
durham
nc
usa
experi
primari
cultur
pt
cell
prepar
male
ko
mice
kidney
age
mice
week
collagenas
digest
renal
cortic
follow
percol
gradient
centrifug
essenti
describ
briefli
kidney
harvest
asept
anesthet
mice
renal
cortic
dissect
gentli
minc
suspend
perfus
solut
consist
mm
nacl
nahco
kcl
na
hpo
mgso
cacl
na
lactat
dglucos
lalanin
acid
hepe
bovin
serum
albumin
bsa
collagenas
type
v
sigma
st
loui
mo
usa
soybean
trypsin
inhibitor
sigma
ph
suspens
gass
co
min
collagenas
digest
cortic
suspens
strain
mm
brass
siev
centrifug
g
min
pellet
wash
phosphatebuff
salin
pb
resuspend
percol
solut
sigma
ph
contain
mm
nacl
kcl
nahco
mgcl
nah
po
dglucos
hepe
lalanin
cacl
uml
penicillin
mgml
streptomycin
solut
centrifug
g
min
digest
tissu
separ
four
distinct
band
fourth
band
enrich
pt
segment
aspir
suspend
cultur
medium
centrifug
remov
percol
solut
mice
final
pt
pellet
suspend
cultur
medium
seed
onto
cultur
dish
cell
initi
grown
defin
medium
supplement
insulin
mgml
transferrin
mgml
selenium
ngml
hydrocortison
nm
nm
uml
penicillin
mgml
streptomycin
fetal
bovin
serum
fb
h
cell
attach
cultur
dish
switch
defin
serumfre
medium
glucos
concentr
mm
day
cell
reach
confluenc
typic
epitheli
cell
morpholog
cobbleston
appear
cell
maintain
humidifi
incub
co
room
air
medium
chang
everi
day
time
experiment
typic
day
cultur
experi
assess
timedepend
accumul
activ
condit
media
media
chang
day
plate
subsequ
chang
media
day
cultur
cell
remain
viabl
retain
cobbleston
morpholog
maneuv
experi
subconflu
pt
cell
incub
hr
vari
concentr
ang
ii
vehicl
control
use
consist
cell
expos
equival
amount
dmso
affect
activ
media
compar
nondmso
treat
cell
primari
cultur
pt
cell
deriv
ko
mice
transient
transfect
human
express
vector
cdna
encod
fulllength
human
gene
clone
xhoi
restrict
site
express
vector
invitrogen
carlsbad
ca
usa
neg
control
cell
transfect
empti
vector
one
day
prior
transfect
subconflu
pt
cell
place
defin
medium
without
antibiot
cell
transient
transfect
mg
plasmid
empti
vector
cultur
dish
use
lipofectamin
tm
ltx
reagent
per
supplier
protocol
invitrogen
hr
activ
protein
express
cell
lysat
cultur
medium
assay
time
point
hr
measur
activ
chosen
base
preliminari
experi
transient
transfect
pt
cell
deriv
wildtyp
mice
result
signific
increas
activ
media
hr
vs
untransfect
control
cell
transfect
empti
vector
n
detect
increas
activ
hr
enzymat
activ
assay
activ
cell
cultur
media
membran
fraction
measur
use
commerci
avail
synthet
fluorogen
substrat
mcaalaproli
dnp
oh
anaspec
san
jose
ca
usa
essenti
describ
cell
media
collect
follow
addit
proteas
inhibitor
cocktail
volvol
sigma
experi
media
first
centrifug
g
min
remov
dead
cell
cellular
debri
cell
membran
fraction
pt
cell
isol
previous
describ
cell
media
ml
membran
fraction
mg
ad
well
plate
total
volum
mlwell
solut
contain
mm
me
mm
nacl
mm
zncl
mm
nethylmaleimid
nem
mm
phenylmethylsulfonyl
fluorid
pmsf
mm
substrat
without
mm
inhibitor
provid
ore
pharmaceut
cambridg
usa
assay
consist
caus
least
inhibit
activ
condit
media
sampl
see
tabl
sampl
protect
light
incub
hr
plate
shaker
room
temperatur
fluoresc
measur
use
fluostar
galaxi
fluoromet
bmg
labtech
durham
nc
usa
excit
wavelength
nm
emiss
wavelength
nm
preliminari
experi
determin
time
point
hr
incub
fluorogen
substrat
linear
rang
detect
mous
recombin
ngml
r
experi
determin
use
assay
activ
media
sampl
primari
cultur
mous
pt
cell
linear
least
hr
incub
fluorogen
substrat
figur
therefor
hr
incub
chosen
data
collect
activ
determin
subtract
rel
fluoresc
unit
rfu
obtain
presenc
read
absenc
inhibitor
activ
cultur
medium
correct
cell
protein
amount
cultur
dish
report
rfu
per
mg
protein
per
hour
rfumghr
cell
lysat
prepar
buffer
contain
nonidet
mm
pepstatin
mm
leupeptin
mgml
soybean
trypsin
inhibitor
uml
trasylol
mgml
mm
pmsf
mm
tri
hcl
ph
sampl
sonic
sec
incub
ice
hr
follow
centrifug
g
min
remov
insolubl
debri
protein
supernat
mg
use
determin
activ
innozym
tm
tace
activ
kit
calbiochem
standard
curv
gener
assay
use
recombin
human
provid
kit
amount
correct
total
protein
report
ng
mg
protein
cell
cultur
medium
remov
dish
subject
centrifug
remov
dead
cell
insolubl
debri
describ
concentr
nanosep
k
centrifug
devic
pall
corpor
port
washington
ny
usa
concentr
ml
prepar
buffer
consist
mm
trishcl
ph
wtvol
sd
glycerol
wtvol
bromophenol
blue
boil
min
lysat
pt
cell
prepar
buffer
consist
mm
tri
hcl
ph
wtvol
sd
glycerol
mm
dtt
wtvol
bromophenol
blue
boil
min
centrifug
g
min
remov
insolubl
debri
twentyf
ml
concentr
media
concentr
mg
protein
cell
lysat
mg
protein
mous
kidney
cortex
run
sdspolyacrylamid
gel
subject
immunoblot
analysi
use
commerci
avail
goat
antihuman
antibodi
dilut
r
system
inc
previous
describ
densitometr
analysi
protein
band
perform
use
kodak
id
imag
analysi
softwar
eastman
kodak
rochest
ny
usa
experi
prior
immunoblot
analysi
concentr
medium
cell
lysat
subject
deglycosyl
use
peptid
nglycosidas
f
pngase
f
new
england
biolab
ipswich
usa
accord
manufactur
instruct
sampl
denatur
sd
mm
dtt
min
cool
room
temperatur
sampl
incub
mm
sodium
phosphat
ph
volvol
u
pngase
f
hr
cell
cultur
medium
concentr
ultrafiltr
amicon
k
centrifug
filter
devic
millipor
follow
immunoprecipit
pierc
classic
ip
kit
pierc
biotech
rockford
il
usa
briefli
ml
concentr
cell
medium
contain
proteas
inhibitor
cocktail
sigma
incub
mg
goat
antihuman
antibodi
r
system
inc
ml
ip
lysiswash
buffer
hr
antigenantibodi
complex
captur
ad
sampl
spin
column
contain
ml
protein
ag
resin
follow
incub
hr
sever
wash
captur
sampl
elut
follow
deglycosyl
pngase
f
concentr
cultur
medium
pt
cell
deriv
ko
mice
appli
neg
control
nonspecif
bind
antigenantibodi
deglycosyl
immunoprecipit
polypeptid
condit
cell
cultur
medium
separ
sdspolyacrylamid
gel
subject
silver
stain
use
silverquest
silver
stain
kit
invitrogen
polypeptid
band
match
identifi
immunoblot
excis
destain
protein
ingel
digest
use
trypsin
promega
madison
wi
usa
describ
result
peptid
extract
purifi
ziptip
milllipor
concentr
vacufug
eppendorf
hamburg
germani
resuspend
formic
acid
thermo
fisher
scientif
waltham
usa
peptid
analyz
liquid
chromatographytandem
mass
spectrometri
lcmsm
ultim
rslc
nano
hplc
dionex
sunnyval
ca
usa
ltq
orbitrap
xl
hybrid
mass
spectromet
nanospray
ioniz
sourc
thermo
fisher
scientif
ottawa
hospit
research
institut
proteom
core
facil
ottawa
ontario
canada
system
control
xcalibur
softwar
version
thermo
fisher
scientif
peptid
load
onto
captrap
column
michrom
bioresourc
auburn
ca
usa
min
flow
rate
mlmin
elut
min
gradient
acetonitril
formic
acid
flow
rate
mlmin
onto
long
column
integr
emitt
tip
picofrit
new
object
woburn
usa
pack
zorbax
micron
agil
santa
clara
ca
usa
nanospray
mass
spectromet
ms
scan
acquir
ftm
mode
resolut
set
ms
scan
acquir
ion
trap
cid
mode
use
datadepend
acquisit
top
ion
ms
scan
mascot
softwar
version
matrix
scienc
boston
usa
use
infer
peptid
protein
ident
mass
spectra
observ
msm
spectra
match
custom
databas
protein
sequenc
mous
sequenc
version
uniprotsprotfastagz
download
ftpuniprotorg
concaten
contamin
databas
download
maxquantorg
june
mass
toler
paramet
ppm
da
data
present
mean
se
data
analyz
use
sigmastat
version
systat
multipl
comparison
analysi
oneway
analysi
varianc
follow
bonferroni
correct
comparison
involv
two
group
student
ttest
use
p
valu
consid
signific
ectodomain
shed
mous
pt
cell
type
integr
membran
protein
catalyt
activ
ectodomain
shed
cell
surfac
retain
activ
extracellular
space
primari
cultur
mous
pt
cell
timedepend
increas
enzymat
activ
detect
media
suggest
constitut
shed
figur
shown
figur
lysat
primari
cultur
mous
pt
cell
detect
protein
kda
immunoblot
consist
size
detect
mous
kidney
cortex
howev
concentr
media
mous
pt
cell
immunoblot
analysi
reveal
fragment
kda
kda
experi
determin
fragment
could
shed
pt
cell
deriv
gene
ko
mice
transfect
plasmid
express
human
cdna
detect
immunoblot
either
cell
lysat
media
untransfect
pt
cell
deriv
ko
mice
contrast
transfect
human
plasmid
result
detect
expect
singl
band
human
kda
cell
lysat
cell
media
contain
band
kda
kda
figur
furthermor
untransfect
cell
cell
transfect
empti
plasmid
demonstr
measur
activ
media
cell
transfect
human
cdna
signific
level
activ
media
hr
figur
vs
untransfect
control
empti
vector
n
cell
media
deriv
mous
pt
cell
incub
enzym
pngase
f
determin
shed
fragment
glycosyl
shown
figur
pt
cell
lysat
fulllength
decreas
size
kda
kda
deglycosyl
similarli
mous
kidney
cortex
lysat
size
reduc
kda
kda
treatment
pngase
f
deglycosyl
decreas
size
mous
fragment
cell
media
kda
kda
kda
kda
respect
cell
lysat
deriv
mous
ko
pt
cell
transfect
human
cdna
reduct
size
kda
kda
observ
deglycosyl
human
fragment
cell
media
also
decreas
size
deglycosyl
kda
kda
kda
kda
respect
experi
conduct
identifi
peptid
fragment
shed
primari
cultur
mous
pt
cell
concentr
media
sampl
mous
pt
cell
immunoprecipit
antibodi
treat
pngase
f
separ
silverstain
sdspage
gel
trypsin
digest
kda
mous
fragment
follow
lcm
ms
analysi
identifi
peptid
match
sequenc
mous
amino
acid
posit
correspond
polypeptid
predict
molecular
mass
kda
figur
tabl
cterminu
met
detect
kda
fragment
repres
site
nontrypt
cleavag
candid
site
ectodomain
cleavag
lcmsm
analysi
immunoprecipit
kda
fragment
addit
separ
experi
reveal
peptid
cterminu
arg
tryptic
cleavag
site
kda
mous
fragment
trypsin
digest
lcmsm
analys
separ
experi
identifi
peptid
correspond
amino
acid
mous
correspond
predict
molecular
mass
kda
figur
tabl
ctermin
amino
acid
arg
correspond
tryptic
cleavag
site
cleavag
site
fragment
therefor
predict
locat
ctermin
arg
could
occur
ly
next
ctermin
tryptic
cleavag
site
experi
lcmsm
analysi
detect
ctermin
ly
tryptic
cleavag
site
correspond
fragment
predict
molecular
mass
kda
fragment
cleavag
site
could
lie
ly
arg
sinc
arg
next
ctermin
site
access
tryptic
digest
altern
proteas
chymotrypsin
glutamyl
endopeptidas
use
peptid
repres
region
interest
arg
ly
identifi
strategi
data
shown
summari
sequenc
data
main
shed
fragment
deglycosyl
kda
kda
fragment
identifi
lcmsm
shown
figur
figur
stimulatori
effect
ang
ii
activ
cultur
media
block
coincub
losartan
suggest
bind
ang
ii
pt
receptor
requir
mediat
effect
figur
osmot
control
incub
cell
lglucos
mm
effect
activ
media
furthermor
addit
dglucos
mm
media
without
cell
incub
effect
activ
n
shown
incub
pt
cell
high
dglucos
mm
hr
significantli
affect
activ
cell
membran
fraction
compar
cell
mm
dglucos
shown
n
gener
inhibitor
matrix
metalloproteinas
signific
effect
constitut
shed
pt
cell
media
high
glucosestimul
shed
determin
activ
assay
figur
lower
higher
concentr
affect
constitut
high
glucoseinducd
shed
data
shown
n
determin
role
stimul
activ
media
induc
high
dglucos
mous
pt
cell
preincub
inhibitor
signific
effect
constitut
shed
activ
media
figur
howev
caus
dosedepend
inhibit
high
dglucoseinduc
shed
signific
inhibit
control
rfumghr
vs
high
dglucos
rfumghr
vs
high
dglucos
rfumg
hr
n
also
partli
inhibit
small
signific
increas
activ
media
induc
ang
ii
figur
tabl
detail
analys
peptid
overal
match
sequenc
cover
mous
sequenc
tabl
detail
amino
acid
met
detect
nontrypt
cleavag
suggest
cleavag
site
ectodomain
shed
mous
media
studi
role
mediat
high
dglucoseinduc
shed
experi
perform
inhibitor
concentr
describ
effect
constitut
shed
caus
signific
inhibit
high
dglucoseinduc
shed
figur
lower
concentr
significantli
block
high
dglucoseinduc
shed
hr
incub
high
dglucos
mm
cellassoci
activ
significantli
increas
compar
control
cell
incub
mm
dglucos
mm
lglucos
figur
determin
stimulatori
effect
high
dglucos
ang
ii
activ
cell
media
accompani
increas
shed
fragment
immunoblot
perform
media
mous
pt
cell
constitut
shed
kda
kda
fragment
evid
unconcentr
media
unstimul
mous
pt
cell
hr
cultur
incub
cell
hr
either
ang
ii
high
dglucos
mm
significantli
increas
intens
band
immunoblot
compar
mm
dglucos
mm
lglucos
figur
besid
kda
kda
fragment
addit
band
detect
immunoblot
media
deriv
cell
expos
high
dglucos
ang
ii
immunoprecipit
antibodi
lcm
ms
analysi
kda
kda
deglycosyl
peptid
fragment
isol
high
dglucos
media
hr
confirm
fragment
deriv
separ
lcmsm
analys
cterminu
kda
fragment
isol
high
glucos
media
correspond
arg
kda
fragment
lcmsm
tabl
detail
analys
peptid
overal
sequenc
coverag
tabl
analys
demonstr
tryptic
fragment
cterminu
arg
consist
fragment
isol
normal
mm
glucos
media
one
analys
reveal
fragment
cterminu
ly
present
studi
first
demonstr
shed
activ
fragment
kidney
pt
cell
find
could
least
partli
account
presenc
solubl
mous
human
urin
also
show
high
glucos
lesser
extent
ang
ii
stimul
releas
pt
cell
may
contribut
mechanist
increas
urinari
level
observ
experiment
human
diabet
inhibit
block
glucosestimul
shed
partli
inhibit
ang
iiinduc
shed
impact
constitut
releas
ectodomain
shed
associ
releas
solubl
glycosyl
peptid
approxim
molecular
mass
kda
kda
fragment
deglycosyl
subject
lcmsm
analysi
reveal
ctermin
met
long
fragment
ctermin
arg
shorter
fragment
predict
molecular
mass
fragment
correspond
approxim
size
kda
kda
respect
gel
acid
type
transmembran
glycoprotein
local
mainli
apic
membran
polar
epitheli
cell
termin
carboxypeptidas
consist
nglycosyl
ntermin
ectodomain
contain
activ
site
amino
acid
hydrophob
transmembran
region
amino
acid
short
ctermin
cytoplasm
tail
amino
acid
cell
surfac
abund
transmembran
protein
may
decreas
result
ectodomain
shed
may
mediat
proteolyt
cleavag
specif
amino
acid
site
constitut
ectodomain
shed
solubl
demonstr
varieti
cultur
cell
includ
cell
endogen
cell
human
airway
epitheli
cell
chines
hamster
ovari
cho
cell
mous
embryon
fibroblast
infect
adenoviru
encod
observ
timedepend
increas
activ
media
unstimul
mous
pt
cell
associ
appear
two
fragment
immunoblot
data
indic
constitut
shed
mous
pt
cell
inde
also
observ
constitut
shed
pt
cell
deriv
ko
mice
transient
transfect
human
cdna
express
vector
immunoblot
enzymat
activ
assay
like
transmembran
metalloproteinas
act
sheddas
cleav
cell
surfac
protein
includ
tumour
necrosi
factora
type
ii
receptor
transform
growth
factora
lambert
et
al
first
report
mediat
proteolyt
cleavag
human
endogen
cell
releas
solubl
glycosyl
fragment
size
kda
kda
phorbol
esterstimul
releas
block
inhibit
gener
metalloproteas
inhibit
hydroxymatebas
inhibitor
also
shown
significantli
inhibit
phorbol
esterstimul
shed
cho
cell
littl
effect
constitut
shed
cell
basal
shed
significantli
affect
either
contrast
constitut
shed
solubl
human
airway
epitheli
cell
reduc
inhibit
phorbol
esterstimul
releas
suggest
promin
role
cleavag
cell
interestingli
studi
complet
block
high
glucosestimul
shed
pt
cell
caus
partial
inhibit
ang
iistimul
shed
effect
constitut
releas
inhibitor
also
inhibit
high
glucosestimul
shed
pt
cell
contrast
gener
metalloproteinas
inhibit
impact
constitut
shed
significantli
inhibit
high
glucosestimul
shed
data
therefor
suggest
basal
shed
pt
cell
mediat
proteas
rel
lack
tissu
inhibitor
metalloproteinas
timp
inde
sinc
inhibitor
use
studi
highli
select
data
support
possibl
role
adam
metalloproteinas
shed
pt
cell
identifi
major
cleav
fragment
immunoblot
media
pt
cell
glycosyl
fragment
ran
kda
kda
gel
collect
retain
enzymat
activ
although
determin
differenti
enzymat
activ
fragment
presenc
ectodomain
sequenc
predict
retent
activ
support
hypothesi
iwata
et
al
demonstr
deglycosyl
solubl
shed
fragment
human
kda
kda
retain
equival
enzymat
activ
result
first
suggest
fragment
may
shed
renal
tubular
cell
wysocki
et
al
detect
dbdb
diabet
mous
urin
sampl
immunoblot
molecular
size
kda
kda
larger
band
consist
size
fulllength
chodavarapu
et
al
report
fragment
molecular
size
kda
kda
urin
dbdb
mice
larger
band
correspond
observ
immunblot
kidney
lysat
deglycosyl
studi
character
urinari
fragment
requir
determin
correspond
mous
pt
fragment
identifi
current
studi
present
studi
show
high
glucos
ang
ii
stimul
shed
solubl
fragment
equival
size
fragment
releas
unstimul
cell
fragment
identifi
begin
gln
consist
presenc
acid
signal
peptid
sequenc
nterminu
unstimul
cell
long
solubl
fragment
shown
contain
met
ctermin
posit
subject
tryptic
digest
site
found
one
experi
separ
sampl
identifi
trypsinsensit
arg
cterminu
similarli
stimul
cell
ctermin
amino
acid
long
fragment
identifi
arg
separ
experi
use
seri
synthes
peptid
correspond
extracellular
juxtamembran
region
human
lai
et
al
report
arg
arg
may
play
role
site
recognit
shed
mediat
put
cleavag
site
shed
identifi
bond
arg
ser
human
mous
amino
acid
sequenc
contain
conserv
residu
arg
arg
arg
follow
gli
suggest
speciesspecif
cleavag
site
may
exist
regard
studi
direct
lcmsm
analysi
fragment
media
ko
cell
stabli
transfect
human
cdna
vector
could
provid
support
inform
data
support
met
potenti
cleavag
site
although
rule
possibl
cleavag
site
proxim
includ
arg
sinc
would
gener
fragment
might
distinguish
gel
electrophoresi
arg
identifi
ctermin
amino
acid
shorter
kda
deglycosyl
fragment
unstimul
stimul
pt
cell
sinc
repres
trypsinsensit
cleavag
site
possibl
cleavag
site
fragment
may
downstream
arg
perhap
posit
ly
next
tryptic
cleavag
site
select
aliphat
hydrophob
residu
posit
immedi
downstream
cleavag
site
amino
acid
arg
asn
hydrophil
residu
although
consider
variabl
exist
substrat
recognit
site
jia
et
al
report
mutat
leu
human
ala
prevent
shed
suggest
repres
sheddas
recognit
motif
whether
posit
conserv
mous
put
cleavag
site
shorter
fragment
remain
unclear
peptid
fragment
cterminu
ly
tryptic
cleavag
site
identifi
lcmsm
immunoprecipit
shorter
fragment
experi
constitut
shed
experi
glucosestimul
shed
signific
find
uncertain
although
peptid
could
repres
addit
fragment
constitut
shed
albeit
lower
level
compar
kda
kda
fragment
biolog
relev
shed
pt
cell
unknown
mice
diabet
exhibit
increas
kidney
express
associ
high
level
urinari
activ
shed
fragment
human
increas
urinari
level
associ
higher
risk
type
diabet
predict
microalbuminuria
suggest
urinari
may
biomark
earli
diabet
nephropathi
consist
observ
studi
high
glucos
stimul
pt
cell
activ
led
increas
shed
contrast
ang
ii
significantli
increas
activ
although
partli
inhibit
ang
iistimul
shed
regard
effect
ang
ii
shed
rel
minor
increas
activ
induc
ang
ii
may
limit
detect
enzym
assay
taken
togeth
result
suggest
increas
lumin
activ
occur
diabet
kidney
stimul
high
glucos
ang
ii
shed
could
serv
dampen
level
ang
ii
pt
lumen
increas
ang
product
hand
ectodomain
shed
ace
shown
occur
polar
renal
epitheli
cell
ndomain
ace
fragment
present
human
urin
may
associ
hypertens
although
studi
pt
ace
shed
intrigu
specul
rel
balanc
shed
ace
fragment
could
regul
local
level
ang
ii
ang
urinari
space
summari
mous
pt
cell
constitut
shed
enzymat
activ
glycosyl
fragment
molecular
mass
kda
kda
releas
fragment
stimul
high
glucos
ang
ii
manner
depend
diabet
nephropathi
enhanc
pt
shed
fragment
via
could
increas
ang
ii
degrad
capac
urin
could
serv
biomark
earli
kidney
injuri
